Misplaced Pages

ViS Research

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
(Redirected from ViS Research Institute)
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (June 2019) (Learn how and when to remove this message)
This article's use of external links may not follow Misplaced Pages's policies or guidelines. Please improve this article by removing excessive or inappropriate external links, and converting useful links where appropriate into footnote references. (June 2019) (Learn how and when to remove this message)
This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (September 2018)
This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "ViS Research" – news · newspapers · books · scholar · JSTOR (November 2020) (Learn how and when to remove this message)
(Learn how and when to remove this message)
ViS Research, Inc.
ViS Research
Company typeIncorporated
Industry
FoundedNew York City, USA (2013)
FounderFabio Thiers, MD, PhD
HeadquartersNew York City
Number of locationsUnited States
Area servedWorldwide
Key peopleFabio Thiers (CEO)
ProductsLocation Analytics
Center Analytics
Analytics Services
Number of employees50+ (April 1, 2013)
Websitewww.visresearch.com Edit this on Wikidata

ViS Research was an American company that conducted clinical trial planning with a site feasibility platform. The ViS online platform provided tools and analytics to pharmaceutical and biotechnology companies and contract research organizations. Its objective was to transform how locations, research centers, and investigators were evaluated for inclusion in clinical trials.

ViS was acquired by IQVIA (formerly known as IMS Health - Quintiles) in June 2015.

References

External links

Categories: